16:35 EDT Sonnet BioTherapeutics files to sell common stock, no amount given
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on SONN:
- Sonnet BioTherapeutics announces 1-for-22 reverse stock split
- Sonnet BioTherapeutics assumed with a Buy at EF Hutton
- Sonnet BioTherapeutics price target lowered to $12 from $14 at Chardan
- Sonnet BioTherapeutics announces FDA acceptance of IND for SB221 trial
- Sonnet BioTherapeutics reports Q3 EPS (13c) vs. ($1.82) last year